Luminex Gains Rights to ViroNovative IP for Use in Respiratory Viral Panel

Jul 14, 2008

NEW YORK (GenomeWeb News) – Luminex said today that it has signed an agreement with Dutch diagnostic developer ViroNovative that gives it worldwide rights to use the company’s human metapneumovirus intellectual property in its xTAG Respiratory Viral Panel.

Luminex said that its distributors and end-user customers around the world also have rights to use the ViroNovative IP under the terms of the agreement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Sharing, But Kinda Sorta

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

This Week in Science

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

Structural Biologist Leads India's CSIR

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

Upward of One Hundred

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Main menu